Calithera Biosciences, Inc. Gains 300%
Thu, Sep 12, 2024 at 05:30 PM
Calithera Biosciences, Inc. (CALA:NASDAQ) jumped higher at $0.05, representing a gain of 300%. On Wed, Sep 11, 2024, CALA:NASDAQ touched a New 2-Week High of $0.05. From Thu, Aug 29, 2024, the stock recorded 25.00% Up Days and 11.11% Green Days
About Calithera Biosciences, Inc. (CALA:NASDAQ)
Calithera Biosciences Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.
Top 10 Gainers:
- Calithera Biosciences, Inc. (CALA:NASDAQ), 300%
- Edgio Inc Com (EGIO:NASDAQ), 118.7%
- Visionary Education Technology Holdings Group Inc. (GV:NASDAQ), 117.73%
- Oblong Inc. (OBLG:NASDAQ), 92.92%
- SRAX, Inc. (SRAX:NASDAQ), 66.67%
- Monopar Therapeutics Inc. (MNPR:NASDAQ), 64.58%
- Till Capital Ltd. (TIL:NASDAQ), 56.69%
- Manitex International, Inc. (MNTX:NASDAQ), 47.77%
- Tenon Medical Inc. (TNON:NASDAQ), 45.21%
- Smart for Life Inc. (SMFL:NASDAQ), 42.35%